Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is an increasingly recognized disorder associated with high mortality rates. The pathomechanisms of CUA are only partially understood ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Sodium thiosulfate, administered before and after reperfusion for STEMI, did not improve infarct ...

Vials of drug Currently, there is no approved therapy for calciphylaxis. Intravenous sodium thiosulfate does not improve skin lesions or reduce the risk of dying from calciphylaxis, a rare but ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Use of sodium thiosulfate to treat calciphylaxis in patients on peritoneal dialysis can be ...

Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology's 71 st Annual ...

Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with ...

RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the U.S.

The evaluation committee considered evidence submitted by Norgine, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers for ...